Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2007 Nov;91(11):1563-4.
doi: 10.1136/bjo.2007.115626.

Rituximab for the treatment of extranodal marginal zone B-cell lymphoma of the lacrimal gland

Case Reports

Rituximab for the treatment of extranodal marginal zone B-cell lymphoma of the lacrimal gland

Carsten Heinz et al. Br J Ophthalmol. 2007 Nov.
No abstract available

PubMed Disclaimer

Conflict of interest statement

Competing interests: None.

Similar articles

Cited by

References

    1. Charlotte F, Doghmi K, Cassoux N.et al Ocular adnexal marginal zone B cell lymphoma: a clinical and pathologic study of 23 cases. Virchows Arch 2006448506–516. - PubMed
    1. Nuckel H, Meller D, Steuhl K P.et al Anti‐CD20 monoclonal antibody therapy in relapsed MALT lymphoma of the conjunctiva. Eur J Haematol 200473258–262. - PubMed
    1. Ferreri A J, Ponzoni M, Martinelli G.et al Rituximab in patients with mucosal‐associated lymphoid tissue‐type lymphoma of the ocular adnexa. Haematologica 2005901578–1579. - PubMed
    1. Asproudis I, Gorezis S, Charonis G C.et al Mucosa‐associated lymphoid tissue lymphoma of the lacrimal gland—a case report. In Vivo 2005191105–1109. - PubMed
    1. Pijpe J, van Imhoff G W, Vissink A.et al Changes in salivary gland immunohistology and function after rituximab monotherapy in a patient with Sjogren's syndrome and associated MALT lymphoma. Ann Rheum Dis 200564958–960. - PMC - PubMed

MeSH terms